Leadership Team

Leadership Team

Darin Hammers

Chief Executive Officer

Darin Hammers has served as Chief Executive Officer of the Company since September 2018. Mr. Hammers’ experience includes over 25 years of increasing leadership roles in Gynecology and Urology. Prior to joining DYSIS, he served as the President and CEO of Cogentix Medical which was acquired by Laborie in April of 2018.  He joined Cogentix’s predecessor company Uroplasty as Vice President of Global Sales in January 2013 and was promoted to Chief Operating Officer prior to being named interim President and CEO in May 2016, and President and CEO in July 2016. Prior to joining Uroplasty, Mr. Hammers was Vice President of Sales for Bard Medical Division of C.R. Bard based in Covington, GA, focused on Urology care products. Prior to that, Mr. Hammers spent more than 12 years with Boston Scientific in various sales leadership positions in the Urology/Gynecology areas.

Alastair Atkinson

Chief Operating Officer

Alastair has over 25 years of Product Marketing, Development, Manufacturing and Sales experience within both corporate and start-up environments. He joined DYSIS Medical from Optos plc where he served as the European General Manager, Global Product Director and was a member of the Senior Management team that floated the company on the main London market in 2006. Prior to joining Optos Mr Atkinson had an 18 year career with Hewlett Packard holding a number of national and international positions. He has a BSc from Reading University, an MSc from Bristol University and completed the Advanced Management Program at INSEAD.

Ed Cordell

Chief Financial Officer

Ed has over 25 years of experience as a Chief Financial Officer for both private and publicly traded medical device companies.  Most recently he served as CFO of Solsys Medical which markets advanced wound care products that treat difficult-to-heal chronic wounds.  Ed has also served in senior financial roles for Given Imaging, a gastroenterology company that created the PillCam, Novoste, a cardiology company that launched the Beta-Cath System using radiation to treat coronary restenosis and CryoLife, an NYSE traded company and leading provider of preserved cardiac and vascular tissues, surgical adhesives and other medical devices. Ed graduated from The University of Tennessee – Chattanooga with a degree in Accounting and was employed as a Certified Public Accountant with Grant Thornton in their Atlanta, GA office.